Answer all questions in simplest language possible

Reading File
Running Command

cd /tmp/workspace/attachments/299692c6-adde-43c7-a2d0-55eb7fc32b2d/ && python3 -c " import pdfplumber with pdfplumber.open('Biochemistry LAQs paper 1.pdf') as pdf: print(f'Total pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages): text = page.extract_text() print(f'--- PAGE {i+1} ---') print(text) print() "

Reading File
Finding Sources
Finding Sources
Finding Sources
Here are all 12 topics answered in the simplest possible language:

Biochemistry LAQs - Paper 1 - Simple Answers


1. VITAMIN D METABOLISM

1. Endogenous Synthesis in Skin

  • Sunlight (UV-B) hits the skin and converts a cholesterol-like compound (7-dehydrocholesterol) into Vitamin D3 (cholecalciferol).
  • Think of it as: Sun + skin cholesterol = Vitamin D3

2. Sequential Hydroxylations (Making the Active Form)

Vitamin D3 is useless on its own. It must be activated in two steps:
StepWhereEnzymeProduct
1st hydroxylationLiver25-hydroxylase25-(OH)D3 (calcidiol) - storage form
2nd hydroxylationKidney1α-hydroxylase1,25-(OH)₂D3 (calcitriol) - ACTIVE form
  • Calcitriol is the fully active hormone.
  • Low calcium or PTH stimulates the kidney to make more calcitriol.

3. Role in Calcium Homeostasis

Calcitriol does 3 things to raise blood calcium:
  1. Gut - increases calcium absorption from food
  2. Bone - releases calcium from bones (with PTH)
  3. Kidney - reduces calcium loss in urine
Simple rule: Calcitriol = raises blood calcium

4. Deficiency Disorders

  • ChildrenRickets: soft, deformed bones; bow legs, knock knees, "rachitic rosary" on ribs
  • AdultsOsteomalacia: soft bones, bone pain, muscle weakness
  • Elderly/severeOsteoporosis (combined with other factors)
  • Cause of deficiency: lack of sunlight, poor diet, kidney disease (can't make calcitriol), liver disease

2. FATTY ACIDS

1. Activation (Turning Fat into a Usable Form)

  • Fatty acids must be "activated" before they can be burned.
  • They combine with CoA (coenzyme A) to form Fatty acyl-CoA.
  • This happens in the cytoplasm (cytosol).
  • Enzyme: Acyl-CoA synthetase (also called thiokinase)
  • Costs 2 ATP (ATP → AMP, so equivalent to 2 ATP lost)

2. Mitochondrial Transport - The Carnitine Shuttle

  • Fatty acyl-CoA is too big to cross the mitochondrial inner membrane on its own.
  • Carnitine acts as a "ferry" or "taxi" to carry it across.
Steps:
  1. Fatty acyl-CoA + Carnitine → Acylcarnitine (enzyme: CPT-1, on outer membrane)
  2. Acylcarnitine crosses the inner membrane via a transporter
  3. Inside: Acylcarnitine → Fatty acyl-CoA + Carnitine released (enzyme: CPT-2)
  4. Carnitine ferries back out
  • CPT-1 is the rate-limiting step and is inhibited by malonyl-CoA (so when you're making fat, you don't burn it at the same time - smart!)

3. Reactions of the Spiral (Beta-oxidation) Pathway

Each "round" of beta-oxidation removes 2 carbons as Acetyl-CoA:
StepReactionProduct
1OxidationFADH₂ produced
2Hydration (water added)-
3Oxidation againNADH produced
4Thiolysis (cut by CoA)Acetyl-CoA released + shorter fatty acyl-CoA
This repeats (spirals) until the whole chain is gone.

4. Energy from Palmitic Acid (16 carbons)

  • Palmitic acid (C16) goes through 7 rounds of beta-oxidation
  • Products: 8 Acetyl-CoA + 7 FADH₂ + 7 NADH
Calculating ATP:
  • 8 Acetyl-CoA × 10 ATP = 80 ATP
  • 7 FADH₂ × 1.5 ATP = 10.5 ATP
  • 7 NADH × 2.5 ATP = 17.5 ATP
  • Total = 108 ATP
  • Subtract 2 ATP for activation = Net 106 ATP

5. Associated Metabolic Blocks

  • Carnitine deficiency: Can't transport fatty acids into mitochondria → fat accumulates, muscle weakness, hypoglycemia
  • CPT-1 deficiency: Same result as carnitine deficiency
  • MCAD deficiency (medium-chain acyl-CoA dehydrogenase): Can't oxidize medium-chain fats; dangerous in fasting - hypoglycemia, sudden death in children
  • Refsum disease: Can't oxidize branched-chain fatty acids → nerve damage

3. VITAMIN B12

1 & 2. Absorption and Transport (Intrinsic Factor)

  • B12 from food binds to R-protein (haptocorrin) in saliva first.
  • In the stomach, Intrinsic Factor (IF) is made by parietal cells.
  • In the small intestine, R-protein is digested off and B12 binds to IF.
  • The B12-IF complex is absorbed in the terminal ileum (last part of small intestine) via specific receptors (cubilin).
  • In blood, B12 is carried by proteins called transcobalamin I, II, III.
  • Transcobalamin II is the most important for delivery to cells.

3. Biochemical Role as a Coenzyme

B12 (cobalamin) acts as a coenzyme in 2 key reactions:
Reaction 1 (uses methylcobalamin):
  • Converts homocysteine → methionine
  • Enzyme: methionine synthase
  • Also regenerates THF (tetrahydrofolate) from methyl-THF
  • This is the link between B12 and folate!
Reaction 2 (uses adenosylcobalamin):
  • Converts methylmalonyl-CoA → succinyl-CoA
  • Enzyme: methylmalonyl-CoA mutase
  • Important for odd-chain fatty acid oxidation
  • Deficiency → methylmalonic acid builds up in blood/urine (diagnostic marker)

4. Neurological Manifestations

B12 deficiency causes nerve damage because myelin (nerve insulation) breaks down:
  • Subacute combined degeneration of spinal cord - affects both sensory and motor tracts
  • Symptoms: Tingling/numbness in hands & feet (peripheral neuropathy), balance problems, difficulty walking, dementia, depression, memory loss
  • Remember: folate deficiency gives anemia but NOT the neurological damage

5. The Folate Trap

  • B12 is needed to convert methyl-THF → THF
  • Without B12, all folate gets "trapped" as methyl-THF (a dead-end form)
  • THF is needed to make DNA building blocks
  • So B12 deficiency → effectively traps folate → can't make DNA → megaloblastic anemia (same as folate deficiency anemia)
  • This is why giving folate to a B12-deficient patient fixes the blood but doesn't fix the nerve damage - a dangerous situation!

4. CHOLESTEROL BIOSYNTHESIS

1. Intracellular Pathway from Acetyl-CoA

Simple steps:
  1. 2 Acetyl-CoA → Acetoacetyl-CoA
  2. + 1 more Acetyl-CoA → HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) - in cytosol
  3. HMG-CoA → Mevalonate ← RATE-LIMITING STEP (enzyme: HMG-CoA reductase)
  4. Mevalonate → Isoprene units (IPP)
  5. 6 Isoprene units → Squalene (30C)
  6. Squalene → LanosterolCholesterol (27C)
Site: Mostly in liver, in the endoplasmic reticulum (smooth ER)

2. Rate-Limiting Step: HMG-CoA Reductase

  • This enzyme converts HMG-CoA → Mevalonate
  • It is the bottleneck of the whole pathway
  • Statins (e.g., atorvastatin, lovastatin) BLOCK this enzyme → less cholesterol made

3. Feedback Regulation

  • High cholesterol → SREBP (a transcription factor) is kept inactive → less HMG-CoA reductase made
  • Low cholesterol → SREBP becomes active → more HMG-CoA reductase made → more cholesterol
  • Insulin activates HMG-CoA reductase (fed state = make cholesterol)
  • Glucagon and cortisol inhibit it (fasting = save energy)
  • Cholesterol also reduces LDL receptor expression (so less uptake from blood when already plenty)

4. Products Derived from Cholesterol

  • Bile acids/salts - for fat digestion
  • Steroid hormones - cortisol, aldosterone, sex hormones (estrogen, testosterone, progesterone)
  • Vitamin D - made from cholesterol in skin
  • Cell membranes - cholesterol gives rigidity
  • Myelin in nerves

5. GLYCOLYSIS

1. Complete Pathways

Glycolysis = breakdown of glucose (6C) to pyruvate (3C), happening in the cytoplasm
10 steps (simplified):
  1. Glucose + ATP → Glucose-6-phosphate (enzyme: hexokinase/glucokinase)
  2. G-6-P → Fructose-6-phosphate
  3. F-6-P + ATP → Fructose-1,6-bisphosphate (PFK-1 - RATE LIMITING STEP)
  4. F-1,6-BP → 2× DHAP + G3P
  5. DHAP → G3P (so now 2× G3P)
  6. G3P → 1,3-BPG (+ 2 NADH made)
  7. 1,3-BPG → 3-phosphoglycerate (+ 2 ATP by substrate-level phosphorylation)
  8. 3-PG → 2-phosphoglycerate
  9. 2-PG → Phosphoenolpyruvate (PEP)
  10. PEP → Pyruvate (+ 2 ATP) - enzyme: pyruvate kinase
Aerobic fate of pyruvate (oxygen present):
  • Pyruvate → Acetyl-CoA (pyruvate dehydrogenase) → TCA cycle → lots of ATP
Anaerobic fate (no oxygen, e.g., RBCs, exercising muscle):
  • Pyruvate → Lactate (lactate dehydrogenase)
  • This regenerates NAD+ so glycolysis can keep going
  • Net: 2 ATP per glucose (no oxygen)

2. Rate-Limiting Steps

  • Hexokinase/Glucokinase (Step 1)
  • PFK-1 (Step 3) - THE MOST IMPORTANT rate-limiting step
  • Pyruvate kinase (Step 10)

3. Hormonal Regulation

HormoneEffect on GlycolysisMechanism
InsulinActivatesActivates PFK-1, pyruvate kinase
GlucagonInhibitsInactivates PFK-1 via F-2,6-BP reduction
AdrenalineInhibits (in liver)Same as glucagon
  • PFK-1 is activated by: AMP, ADP, F-2,6-BP (low energy signal → make energy)
  • PFK-1 is inhibited by: ATP, citrate (high energy signal → no need to make more)

4. Energetics

ConditionATP MadeATP UsedNet ATP
Anaerobic422 ATP
Aerobic4 + (NADH → ~32 more via TCA/OxPhos)2~32 ATP total
Glycolysis itself only makes: 2 ATP + 2 NADH + 2 Pyruvate

5. Rapoport-Luebering Shunt

  • Normally: 1,3-BPG → 3-PG (makes ATP)
  • In the shunt: 1,3-BPG → 2,3-BPG → 3-PG (NO ATP made!)
  • Why is it important? 2,3-BPG binds to hemoglobin and reduces its affinity for oxygen → hemoglobin releases O₂ more easily to tissues
  • Especially important in RBCs (which cannot make ATP by any other means)
  • Clinical: stored blood has low 2,3-BPG → Hb holds O₂ tightly → tissues don't get enough O₂ (transfusion problem)

6. TCA CYCLE (Krebs Cycle / Citric Acid Cycle)

1. Detailed Steps

Starts with Acetyl-CoA (2C) + Oxaloacetate (4C) = Citrate (6C)
StepReactionImportant Product
1Acetyl-CoA + OAA → Citrate-
2Citrate → Isocitrate-
3Isocitrate → α-ketoglutarateCO₂ + NADH
4α-ketoglutarate → Succinyl-CoACO₂ + NADH (rate-limiting!)
5Succinyl-CoA → SuccinateGTP (= ATP)
6Succinate → FumarateFADH₂
7Fumarate → Malate-
8Malate → OAANADH
Per one Acetyl-CoA turn: 3 NADH + 1 FADH₂ + 1 GTP + 2 CO₂

2. Regulatory Checkpoints

Regulated at 3 enzymes (all inhibited by high energy):
EnzymeActivated byInhibited by
Citrate synthaseLow OAAATP, NADH, succinyl-CoA
Isocitrate dehydrogenaseADPATP, NADH
α-ketoglutarate dehydrogenaseCa²⁺ATP, NADH, succinyl-CoA

3. Energetics (ATP yield per Acetyl-CoA)

  • 3 NADH × 2.5 ATP = 7.5 ATP
  • 1 FADH₂ × 1.5 ATP = 1.5 ATP
  • 1 GTP = 1 ATP
  • Total = 10 ATP per Acetyl-CoA
Per glucose (2 Acetyl-CoA): 20 ATP from TCA alone

4. Amphibolic and Anaplerotic Roles

Amphibolic = the cycle serves BOTH breaking down AND building up:
  • Breaking down: burns acetyl-CoA for energy (catabolism)
  • Building up: provides building blocks for making amino acids, fatty acids, glucose (anabolism)
Anaplerotic = reactions that "fill up" the cycle when intermediates are used up:
  • Most important: Pyruvate carboxylase converts pyruvate → OAA (replenishes OAA)
  • Also: amino acids feed in (e.g., glutamate → α-ketoglutarate)
  • Why needed: if OAA runs low, the cycle slows down even if Acetyl-CoA is available

7. ENZYME INHIBITION

1. Competitive vs Non-Competitive Inhibition

FeatureCompetitiveNon-Competitive
Where inhibitor bindsActive site (competes with substrate)Allosteric site (elsewhere on enzyme)
Can it be overcome?Yes, by adding more substrateNo
Effect on KmINCREASES (lower affinity)No change
Effect on VmaxNo changeDECREASES
ExampleStatins (compete with HMG-CoA)Heavy metal poisoning
Simple memory:
  • Competitive: inhibitor and substrate fight for the same seat. More substrate = inhibitor loses.
  • Non-competitive: inhibitor sits somewhere else and slows the enzyme down regardless.

2. Lineweaver-Burk Plots (Double Reciprocal Plot)

This is a graph of 1/V (y-axis) vs 1/[S] (x-axis):
  • X-intercept = -1/Km
  • Y-intercept = 1/Vmax
Competitive inhibition on the graph:
  • Lines cross on Y-axis (same Vmax)
  • X-intercept shifts (different Km - higher Km with inhibitor)
Non-competitive inhibition on the graph:
  • Lines cross on X-axis (same Km)
  • Y-intercept shifts up (lower Vmax)

3. Changes in Km and Vmax

Inhibitor TypeKmVmax
CompetitiveIncreasesSame
Non-competitiveSameDecreases
MixedIncreasesDecreases
UncompetitiveDecreasesDecreases

4. Clinical Examples

Statins (e.g., atorvastatin)
  • Competitive inhibitor of HMG-CoA reductase
  • Blocks cholesterol synthesis
  • Used for: high cholesterol, preventing heart attacks
Aspirin
  • Irreversible (suicide) inhibitor of COX-1 and COX-2 enzymes
  • Blocks prostaglandin and thromboxane synthesis
  • Effect: anti-platelet, anti-inflammatory, analgesic
  • Irreversible means even adding more arachidonic acid won't help (different from competitive)

8. OXIDATIVE PHOSPHORYLATION

1. The Mitochondrial Respiratory Chain (Complexes I-V)

The inner mitochondrial membrane has 5 protein complexes:
ComplexNameActionTransfers to
INADH dehydrogenaseNADH → NAD⁺; pumps 4H⁺CoQ (ubiquinone)
IISuccinate dehydrogenaseFADH₂ → FAD; NO H⁺ pumpedCoQ
IIICytochrome bc1Pumps 4H⁺Cytochrome C
IVCytochrome c oxidasePumps 2H⁺; O₂ → H₂OTerminal step
VATP synthaseH⁺ flow back → makes ATP-
Mobile carriers: CoQ (between I/II and III), Cytochrome C (between III and IV)

2. Chemiosmotic Theory (Mitchell's Theory)

Simple version:
  1. Complexes I, III, IV pump H⁺ (protons) OUT of the mitochondrial matrix → intermembrane space
  2. This creates a proton gradient (electrochemical gradient) - like a battery
  3. H⁺ wants to flow back in - can only do so through Complex V (ATP synthase)
  4. H⁺ flowing back through Complex V drives ATP synthesis
  5. This is called chemiosmosis - chemical + osmosis (concentration gradient)
Simple analogy: H⁺ pumped out = water behind a dam; ATP synthase = the turbine; H⁺ flowing back = water turning the turbine to generate electricity (ATP)

3. Inhibitors and Uncouplers

Electron transport inhibitors (block H⁺ pumping):
  • Rotenone (insecticide) - blocks Complex I
  • Antimycin A - blocks Complex III
  • Cyanide (CN⁻), CO, Azide - block Complex IV → death (no ATP made, O₂ not used)
ATP synthase inhibitors:
  • Oligomycin - directly blocks Complex V → no ATP made
Uncouplers (make inner membrane leaky to H⁺):
  • H⁺ leaks back WITHOUT going through ATP synthase
  • Gradient is destroyed → no ATP made
  • BUT electrons still flow → energy released as HEAT instead
  • Example: 2,4-DNP (dinitrophenol) - once used as a diet pill (dangerous!)
  • Example: Thermogenin (UCP-1) in brown fat - natural uncoupler that generates heat in newborns/hibernating animals

9. PROTEIN BIOSYNTHESIS (Translation)

1. Phases of Translation in Prokaryotes

Initiation:
  1. Small ribosome subunit (30S) binds to mRNA at the Shine-Dalgarno sequence
  2. Initiator tRNA (fMet-tRNA) comes in - carrying formyl-methionine (fMet)
  3. Large subunit (50S) joins → complete 70S ribosome
  4. Needs: IF1, IF2, IF3 (initiation factors) + GTP
Elongation (repeating cycle):
  1. Aminoacyl-tRNA enters the A site (with EF-Tu + GTP)
  2. Peptide bond formed between growing chain (P site) and new amino acid (A site)
  3. Enzyme: peptidyl transferase (part of 23S rRNA - a ribozyme!)
  4. Ribosome moves one codon forward (translocation) - needs EF-G + GTP
  5. tRNA moves: A→P→E (Exit site)
Termination:
  1. A stop codon (UAA, UAG, UGA) enters the A site
  2. No tRNA fits - instead release factors (RF1, RF2) bind
  3. Polypeptide chain released
  4. Ribosome dissociates

2. Initiation and Elongation Factors

FactorRole
IF1Prevents tRNA from entering A site during initiation
IF2Brings initiator tRNA to ribosome (needs GTP)
IF3Prevents premature joining of large subunit; helps select start codon
EF-TuDelivers aminoacyl-tRNA to A site (needs GTP)
EF-TsRecycles EF-Tu
EF-GCauses translocation (needs GTP)

3. Codon-Anticodon Recognition and Wobble Hypothesis

  • Each codon (3 bases on mRNA) is read by an anticodon (3 bases on tRNA)
  • Positions 1 & 2 of codon must match EXACTLY
  • Position 3 (wobble position) can be flexible - one tRNA can read multiple codons!
Wobble rules:
  • Inosine (I) in tRNA anticodon can pair with U, C, or A in mRNA
  • This means we need FEWER tRNA types than codons (only ~45 tRNA for 61 codons)

4. Post-Translational Modifications

After the protein is made, it's modified:
  • Glycosylation - sugars added (in ER/Golgi) → glycoproteins
  • Phosphorylation - phosphate group added → activates/deactivates proteins (signaling)
  • Methylation, acetylation - common for histone proteins
  • Hydroxylation - proline → hydroxyproline in collagen (needs Vitamin C!)
  • Signal peptide cleavage - signal sequence cut off after protein reaches destination
  • Disulfide bond formation - stabilizes protein structure (in ER)
  • Ubiquitination - tags protein for destruction

10. ACID-BASE REGULATION

1. Buffer Mechanisms

Respiratory buffer (fast, within minutes):
  • Lungs control CO₂
  • Too acidic → breathe faster → blow off CO₂ → pH rises
  • Too alkaline → breathe slower → retain CO₂ → pH falls
  • CO₂ + H₂O ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻
Renal buffer (slow, takes hours-days):
  • Kidneys control HCO₃⁻
  • Too acidic → kidneys absorb more HCO₃⁻, excrete more H⁺ (as NH₄⁺ and H₂PO₄⁻)
  • Too alkaline → kidneys excrete more HCO₃⁻, retain H⁺
  • Bicarbonate buffer is the most important buffer in blood
Other buffers:
  • Hemoglobin (in RBCs) - buffers CO₂ in blood
  • Phosphate buffer - mainly in urine and cells
  • Protein buffer - mainly inside cells

2. Henderson-Hasselbalch Equation

pH = pKa + log ([HCO₃⁻] / [CO₂])
Normal values:
  • pH = 7.4
  • HCO₃⁻ = 24 mEq/L
  • pCO₂ = 40 mmHg
  • Ratio = 20:1 (HCO₃⁻:CO₂)
Simple rule: pH follows HCO₃⁻ and goes against CO₂
  • High CO₂ → acid (pH falls)
  • High HCO₃⁻ → alkaline (pH rises)

3. Compensatory Responses

DisorderPrimary ProblemCompensation
Metabolic acidosis↓ HCO₃⁻Lungs breathe faster → ↓ CO₂ (Kussmaul breathing)
Metabolic alkalosis↑ HCO₃⁻Lungs breathe slower → ↑ CO₂
Respiratory acidosis↑ CO₂Kidneys retain more HCO₃⁻
Respiratory alkalosis↓ CO₂Kidneys excrete more HCO₃⁻
Rule: The body always compensates to bring pH back toward 7.4, but NEVER fully corrects it (that would require removing the primary problem).

11. BILIRUBIN METABOLISM

1. Complete Pathway of Heme Catabolism

Step 1 - In Reticuloendothelial (RE) Cells (spleen, liver, bone marrow):
  • Old RBCs are broken down
  • Hemoglobin → Heme + Globin
  • Heme → Biliverdin (green) - enzyme: heme oxygenase
  • Biliverdin → Bilirubin (yellow/orange) - enzyme: biliverdin reductase
  • At this stage, bilirubin is unconjugated (indirect) bilirubin - fat-soluble, not water-soluble

2. Transport in Blood

  • Unconjugated bilirubin is fat-soluble → can't dissolve in blood alone
  • It binds to albumin for transport to the liver
  • It is NOT in urine at this stage (albumin-bound, too large)

3. Hepatic Conjugation

  • In the liver, bilirubin is taken up from albumin
  • It is conjugated (attached) to glucuronic acid by the enzyme UDP-glucuronosyltransferase (UGT)
  • Now it is conjugated (direct) bilirubin - water-soluble
  • Secreted into bile

4. Intestinal Excretion

  • Conjugated bilirubin enters the gut via bile
  • Gut bacteria convert it to urobilinogen
  • Most urobilinogen → stercobilin (brown color of stool)
  • Small amount of urobilinogen absorbed back into blood → some excreted in urine as urobilin (yellow color of urine)

5. Differential Diagnosis of Jaundice (Yellow skin/eyes)

FeaturePre-hepatic (Hemolytic)Hepatic (Liver disease)Post-hepatic (Obstructive)
CauseToo many RBCs broken downLiver can't process bilirubinBile duct blocked
Bilirubin type↑ UnconjugatedBoth↑ Conjugated
Urine colorNormal (no bilirubin in urine)Dark (urobilinogen)Dark (conjugated bilirubin in urine)
Stool colorNormal/darkPalePale ("clay-colored")
Urine urobilinogen↑↑Absent
ItchingNoVariableYes (bile salts in skin)
ExamplesMalaria, sickle cell, hemolysisHepatitis, cirrhosisGallstones, pancreatic cancer

12. UREA CYCLE

1. Detailed Enzymatic Steps

The urea cycle removes toxic ammonia (NH₃) from the body. It takes place partly in the mitochondria and partly in the cytosol.
Mitochondria steps (2 steps):
  1. NH₃ + CO₂ + 2ATP → Carbamoyl phosphate (enzyme: CPS-1 - carbamoyl phosphate synthetase I)
  2. Carbamoyl phosphate + Ornithine → Citrulline (enzyme: OTC - ornithine transcarbamoylase)
    • Citrulline exits to the cytosol
Cytosol steps (3 steps): 3. Citrulline + Aspartate + ATP → Argininosuccinate (enzyme: argininosuccinate synthetase) 4. Argininosuccinate → Arginine + Fumarate (enzyme: argininosuccinase) 5. Arginine → Ornithine + UREA (enzyme: arginase)
  • Ornithine goes back into mitochondria to repeat the cycle
  • Urea is excreted by kidneys
Inputs: 2 NH₃ (one from mitochondria, one from aspartate) + CO₂ Output: 1 Urea (contains 2 N atoms) Cost: 3 ATP used per urea

2. Biochemical Regulation

  • N-acetylglutamate (NAG) activates CPS-I (the first enzyme)
  • NAG is made when amino acids are abundant → stimulates urea cycle
  • NAG synthase is activated by arginine → positive feedback (more arginine = more urea cycle activity)
  • High protein diet → more amino acid breakdown → more ammonia → more urea cycle activity

3. Connection with TCA Cycle - Krebs Bicycle

  • In Step 4, fumarate is released in the cytosol
  • Fumarate enters the TCA cycle → becomes malate → OAA → aspartate
  • Aspartate comes back to feed Step 3 of the urea cycle again
  • This creates a "bicycle" (two linked cycles):
    • Urea cycle provides fumarate to TCA cycle
    • TCA cycle provides aspartate back to urea cycle
    • They share fumarate and aspartate as the connecting metabolites

4. Hyperammonemia and Urea Cycle Defects

Hyperammonemia = too much ammonia in blood → very toxic to brain
Symptoms of high ammonia (NH₃):
  • Cerebral edema (brain swelling)
  • Vomiting, asterixis (liver flap - tremor)
  • Confusion, coma, death
Mechanism of toxicity:
  • NH₃ + α-ketoglutarate → glutamate → glutamine
  • This depletes α-ketoglutarate from TCA cycle → TCA slows → less ATP → brain cells die
  • Also causes cerebral edema
Genetic Urea Cycle Defects (all autosomal recessive except OTC):
Enzyme DeficientDiseaseKey feature
CPS-ICPS-I deficiencyHigh ammonia, normal orotic acid
OTCOTC deficiencyX-linked; most common; HIGH orotic acid (carbamoyl-P spills into pyrimidine pathway)
Argininosuccinate synthetaseCitrullinemia type 1High citrulline
ArgininosuccinaseArgininosuccinic aciduriaHigh argininosuccinate; brittle hair (trichorrhexis nodosa)
ArginaseArgininemiaHigh arginine; spastic diplegia
Treatment of hyperammonemia:
  • Low protein diet
  • Lactulose (reduces ammonia absorption from gut)
  • Sodium benzoate/phenylbutyrate (alternative pathways to excrete nitrogen)
  • Liver transplant in severe genetic cases

Quick Summary Reference Card

TopicKey EnzymeKey Product/Concept
Vitamin D1α-hydroxylase (kidney)Calcitriol = active form
Fatty acidsCPT-1 (carnitine shuttle)Palmitate → 106 ATP
Vitamin B12Methionine synthaseFolate trap → megaloblastic anemia
CholesterolHMG-CoA reductase (rate-limiting)Statins block this
GlycolysisPFK-1 (rate-limiting)2 ATP anaerobic, ~32 ATP aerobic
TCA cycleIsocitrate DH, α-KG DH10 ATP per Acetyl-CoA
Enzyme inhibitionCompetitive vs non-competitiveKm vs Vmax changes
Oxidative phosphorylationATP synthase (Complex V)Chemiosmosis
Protein synthesisPeptidyl transferaseWobble at position 3
Acid-baseCarbonic anhydraseLungs fast, kidneys slow
BilirubinUGT (conjugation)Conjugated = water-soluble
Urea cycleCPS-I (mitochondria)OTC deficiency = X-linked
This is a shared conversation. Sign in to Orris to start your own chat.